These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37986045)

  • 41. Physician prescribing patterns of innovative antidepressants in the United States: the case of MDD patients 1993-2007.
    Lin HC; Erickson SR; Balkrishnan R
    Int J Psychiatry Med; 2011; 42(4):353-68. PubMed ID: 22530398
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A prospective study in primary care in patients without vascular disease comparing levels of coronary risk factors in those recommended for lipid-lowering drugs based on either absolute risk or absolute risk reduction.
    Ramachandran S; Croft P; Neary RH
    Prev Cardiol; 2003; 6(1):17-21. PubMed ID: 12624557
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential prescribing of opioid analgesics according to physician specialty for Medicaid patients with chronic noncancer pain diagnoses.
    Ringwalt C; Gugelmann H; Garrettson M; Dasgupta N; Chung AE; Proescholdbell SK; Skinner AC
    Pain Res Manag; 2014; 19(4):179-85. PubMed ID: 24809067
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lipid-lowering medication for secondary prevention of coronary heart disease in a German outpatient population: the gap between treatment guidelines and real life treatment patterns.
    Ruof J; Klein G; März W; Wollschläger H; Neiss A; Wehling M
    Prev Med; 2002 Jul; 35(1):48-53. PubMed ID: 12079440
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a clinical practice guideline with risk-stratified recommendations.
    Hao Q; Aertgeerts B; Guyatt G; Bekkering GE; Vandvik PO; Khan SU; Rodondi N; Jackson R; Reny JL; Al Ansary L; Van Driel M; Assendelft WJJ; Agoritsas T; Spencer F; Siemieniuk RAC; Lytvyn L; Heen AF; Zhao Q; Riaz IB; Ramaekers D; Okwen PM; Zhu Y; Dawson A; Ovidiu MC; Vanbrabant W; Li S; Delvaux N
    BMJ; 2022 May; 377():e069066. PubMed ID: 35508320
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inappropriate Prescribing to Older Patients by Nurse Practitioners and Primary Care Physicians.
    Huynh J; Alim SA; Chan DC; Studdert DM
    Ann Intern Med; 2023 Nov; 176(11):1448-1455. PubMed ID: 37871318
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluating the validity of an instrumental variable study of neuroleptics: can between-physician differences in prescribing patterns be used to estimate treatment effects?
    Brookhart MA; Rassen JA; Wang PS; Dormuth C; Mogun H; Schneeweiss S
    Med Care; 2007 Oct; 45(10 Supl 2):S116-22. PubMed ID: 17909369
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Physicians' decisions to prescribe antidepressant therapy in older patients with depression in a US managed care plan.
    Ivanova JI; Bienfait-Beuzon C; Birnbaum HG; Connolly C; Emani S; Sheehy M
    Drugs Aging; 2011 Jan; 28(1):51-62. PubMed ID: 21174487
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries.
    DeJong C; Aguilar T; Tseng CW; Lin GA; Boscardin WJ; Dudley RA
    JAMA Intern Med; 2016 Aug; 176(8):1114-1122. PubMed ID: 27322350
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Using Classification and Regression Trees (CART) to Identify Prescribing Thresholds for Cardiovascular Disease.
    Schilling C; Mortimer D; Dalziel K; Heeley E; Chalmers J; Clarke P
    Pharmacoeconomics; 2016 Feb; 34(2):195-205. PubMed ID: 26578402
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Randomized Study of Providing Evidence Context to Mitigate Physician Misinterpretation Arising From Off-Label Drug Promotion.
    Schwartz LM; Woloshin S; Lu Z; Ross KM; Tessema FA; Peter D; Kesselheim AS
    Circ Cardiovasc Qual Outcomes; 2019 Nov; 12(11):e006073. PubMed ID: 31707825
    [TBL] [Abstract][Full Text] [Related]  

  • 52. National variation in the delivery of radiation oncology procedures in the non-facility-based setting.
    Valle LF; Chu FI; Kundu P; Yoon SM; Gilchrist T; Steinberg ML; Raldow AC
    Cancer Med; 2021 Jul; 10(14):4734-4742. PubMed ID: 34076341
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Secondary prevention in a cardiology group practice and hospital setting after a heart-care initiative.
    LaBresh KA; Owen P; Alteri C; Reilly S; Albright PS; Hordes AR; Shaftel PA; Noonan TE; Stoukides CA; Kaul AF
    Am J Cardiol; 2000 Feb; 85(3A):23A-29A. PubMed ID: 10695704
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regional Variation in Physician Adoption of Antipsychotics: Impact on US Medicare Expenditures.
    Donohue JM; Normand SL; Horvitz-Lennon M; Men A; Berndt ER; Huskamp HA
    J Ment Health Policy Econ; 2016 Jun; 19(2):69-78. PubMed ID: 27453458
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of physician characteristics and knowledge on the quality of dyslipidemia management and LDL-C target goal achievement in China: Subgroup analysis of the Dyslipidemia International Study.
    Ding R; Ye P; Zhao S; Zhao D; Yan X; Dong Y; Li J; Ran Y; Hu D;
    J Glob Health; 2017 Dec; 7(2):020702. PubMed ID: 29057073
    [TBL] [Abstract][Full Text] [Related]  

  • 56. General practitioners' adherence to guidelines on management of dyslipidaemia: ADDITION-Denmark.
    Graversen L; Christensen B; Borch-Johnsen K; Lauritzen T; Sandbaek A
    Scand J Prim Health Care; 2010 Mar; 28(1):47-54. PubMed ID: 19929180
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Determinants of appropriate lipid management in patients with ischaemic heart disease. Cracovian Program for Secondary Prevention of Ischaemic Heart Disease.
    Kawecka-Jaszcz K; Jankowski P; Pajak A
    Int J Cardiol; 2003 Sep; 91(1):15-23. PubMed ID: 12957725
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery.
    Lindenauer PK; Pekow P; Wang K; Gutierrez B; Benjamin EM
    JAMA; 2004 May; 291(17):2092-9. PubMed ID: 15126437
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Off-Label Prescribing for Children with Migraines in U.S. Ambulatory Care Settings.
    Lai LL; Koh L; Ho JA; Ting A; Obi A
    J Manag Care Spec Pharm; 2017 Mar; 23(3):382-387. PubMed ID: 28230456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.